News Sentiment

CALC sentiment intelligence

CalciMedica, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 56 Balanced news tone 47 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.93 Week of 10 Jul 2026
Weighted tone 56/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

78/100 classification confidence.

Company focus 39

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend inactive

-3.7% over one week, +7.3% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?

Market Reaction

Balanced read

64/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 78/100 classification
One-week reaction -3.7% Price reacting lower
Trend fit Trend inactive 7.3% over four weeks
Fair value -69.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 16
Neutral 27
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 39
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 16
Market source 6
TradingView 4
Stocktwits 2
simplywall.st 2
Barron's 2
DirectorsTalk Interviews 1
The Globe and Mail 1

Event Lens

What the news is about

Classified themes
Market update 23
Earnings 17
Deals and strategy 7

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 47
Stock Titan Direct company coverage

CalciMedica (NASDAQ: CALC) plans reverse split and warrant votes

CalciMedica (NASDAQ: CALC) is holding a virtual annual stockholder meeting on August 19, 2026, to vote on eight proposals. Key agenda items include electing directors, ratifying auditors, amending the 2023 Equity Incentive Plan, and advisory votes on executive compensation. Most

Tone
Neutral 50/100
Event
Market update
Published
13 Jul 2026 21:11
Source
Stock Titan
Moomoo Direct company coverage

CalciMedica Stock Short Interest Rises to 33.91%

This article reports a significant increase in short interest for CalciMedica (NASDAQ:CALC) stock, which rose to 33.91% of its float as of June 15th. This represents a substantial increase from the previous reporting period, indicating growing bearish sentiment among investors. T

Tone
Negative 39/100
Event
Market update
Published
11 Jul 2026 14:11
Source
Moomoo
Stock Titan Direct company coverage

CalciMedica (CALC) gains 17.1% shareholder as Alafi Capital ups stake in $2.8M deal

Alafi Capital Company LLC and Christopher D. Alafi have increased their beneficial ownership in CalciMedica, Inc. (CALC) to 17.1%, now holding 5,242,996 shares. This includes a recent acquisition of 3,529,192 units in a private placement for approximately $2.8 million, along with

Tone
Positive 67/100
Event
Deals and strategy
Published
11 Jul 2026 01:09
Source
Stock Titan
TradingView Direct company coverage

Alafi Capital Discloses Investment at CalciMedica with 17.1% Stake

Alafi Capital Company LLC has disclosed a 17.1% stake in CalciMedica, Inc. common stock, filing a Schedule 13D on July 10, 2026. This investment includes shares from a June 2026 private placement and earlier open-market purchases, alongside warrants. Alafi Capital, an Emeryville-

Tone
Positive 66/100
Event
Deals and strategy
Published
10 Jul 2026 21:09
Source
TradingView
www.marketscreener.com Direct company coverage

CalciMedica, Inc. Announces Board Changes, Effective July 2, 2026

CalciMedica, Inc. announced board changes effective July 2, 2026. The board increased its size from seven to eight directors, appointing Evgeny Zaytsev, M.D., Ph.D., as a Class I director. Additionally, Fred Middleton will retire from the board at the 2026 annual meeting of stock

Tone
Neutral 50/100
Event
Market update
Published
08 Jul 2026 13:10
Source
www.marketscreener.com
Stock Titan Direct company coverage

CalciMedica (NASDAQ: CALC) appoints Dr. Evgeny Zaytsev to board

CalciMedica, Inc. (NASDAQ: CALC) has appointed Dr. Evgeny Zaytsev to its board of directors as a Class I director, effective July 2, 2026. This increases the board size from seven to eight, though it will return to seven upon Fred Middleton's retirement at the 2026 annual meeting

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 20:39
Source
Stock Titan
Stock Titan Direct company coverage

Director at CalciMedica (CALC) granted stock options on 20,000 shares

CalciMedica, Inc. director Evgeny Zaytsev was granted stock options for 20,000 shares of common stock, with an exercise price of $0.9654 per share and an expiration date of July 1, 2036. These options will vest in equal monthly installments over three years. This award is compens

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 20:39
Source
Stock Titan
Finviz Direct company coverage

CALC - CalciMedica Inc Options

This article provides a detailed financial overview of CalciMedica Inc. (CALC), including its recent stock performance, key financial metrics, insider and institutional ownership, and analyst recommendations. The data presented covers market capitalization, sales, earnings per sh

Tone
Negative 33/100
Event
Earnings
Published
03 Jul 2026 16:09
Source
Finviz
TradingView Direct company coverage

Bering Partners II Discloses Investment at CalciMedica with 6.9% Stake

Bering Partners II, L.P. has disclosed a 6.9% stake in CalciMedica, Inc., acquiring 1,450,267 units in a private placement and shifting its prior 13G filing to a 13D. The fund also increased its warrant ownership cap to 19.99%, indicating potential for further action. Bering Part

Tone
Positive 66/100
Event
Deals and strategy
Published
03 Jul 2026 00:40
Source
TradingView
Stock Titan Direct company coverage

CalciMedica (NASDAQ: CALC) gains 6.9% holder via June 2026 private placement

Bering Partners II and its affiliates have disclosed a 6.9% beneficial ownership stake in CalciMedica (NASDAQ: CALC), totaling 2,113,513 common shares. This significant position was accumulated through a series of transactions, including the company's merger with Graybug Vision,

Tone
Positive 62/100
Event
Deals and strategy
Published
03 Jul 2026 00:40
Source
Stock Titan
Stock Titan Direct company coverage

CalciMedica (CALC) insiders add shares via open-market and unit purchases

CalciMedica insiders Eric Roberts and A. Rachel Leheny have increased their stakes in the company through open-market purchases and a public offering. Roberts now beneficially owns 6.4% and Leheny 6.3% of CalciMedica's common stock, based on 30,736,401 shares outstanding as of Ju

Tone
Positive 70/100
Event
Market update
Published
01 Jul 2026 09:40
Source
Stock Titan
Investing.com Nigeria Direct company coverage

Form 4 CalciMedica Inc For: 29 June By Investing.com

This article from Investing.com announces the filing of a Form 4 for CalciMedica Inc. on June 29. A Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) whenever there is a change in the ownership of company stock by an insider. The artic

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 10:10
Source
Investing.com Nigeria
Stock Titan Direct company coverage

CalciMedica (CALC) Chief Medical Officer acquires 124,486 shares via board-approved deal

CalciMedica's Chief Medical Officer, Sudarshan Hebbar, acquired 124,486 shares of common stock at an indicated price of $0.8033 per share on June 25, 2026, bringing his total direct holdings to 186,025 shares. This transaction was part of a Securities Purchase Agreement dated Jun

Tone
Positive 67/100
Event
Deals and strategy
Published
29 Jun 2026 22:39
Source
Stock Titan
Stock Titan Direct company coverage

CalciMedica (CALC) insider-affiliated fund buys 248,972 new shares at $0.8033

An investment fund associated with CalciMedica director Fred A. Middleton purchased 248,972 shares of common stock at $0.8033 per share directly from the company. This transaction, approved by an independent board committee, increased the fund's total holdings to 1,063,272 shares

Tone
Positive 73/100
Event
Market update
Published
29 Jun 2026 13:11
Source
Stock Titan
Stock Titan Direct company coverage

Director Robert N. Wilson adds 1.18M CalciMedica (CALC) shares via purchase deal

CalciMedica director Robert N. Wilson acquired 1,182,621 shares of Common Stock at $0.8033 per share through a Securities Purchase Agreement. This transaction, which closed on June 25, 2026, and was approved by an independent board committee, increased his direct holdings to 1,60

Tone
Positive 72/100
Event
Deals and strategy
Published
29 Jun 2026 13:11
Source
Stock Titan
Investing.com Direct company coverage

Calcimedica director Fred Middleton acquires $199,999 in stock.

CalciMedica director Fred Middleton recently acquired 248,972 shares of the company's common stock for approximately $199,999, at a price of $0.8033 per share. This acquisition was made through Sanderling Venture Partners VI Co-Investment Fund, L.P., and adds to Middleton's signi

Tone
Positive 69/100
Event
Deals and strategy
Published
29 Jun 2026 13:11
Source
Investing.com
Stock Titan Direct company coverage

[Form 4] CalciMedica, Inc. Insider Trading Activity

CalciMedica, Inc.'s director, CEO, and 10% owner, Rachel A. Leheny, acquired 186,729 shares of common stock at $0.8033 per share through a Securities Purchase Agreement. This transaction, which closed on June 25, 2026, increased her direct holdings to 317,655 shares. The purchase

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 13:11
Source
Stock Titan
Stock Titan Direct company coverage

CalciMedica (CALC) chief business officer gets 186,729-share stock award at $0.8033

CalciMedica's chief business officer, Eric W. Roberts, was granted 186,729 shares of common stock at a price of $0.8033 per share. This stock award was part of a Securities Purchase Agreement approved by an independent committee of the board of directors. Following this transacti

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 13:11
Source
Stock Titan
Stock Titan Direct company coverage

CalciMedica (NASDAQ: CALC) lenders capped at 4.99% ownership after loan amendment

CalciMedica's lenders are capped at 4.99% ownership due to an amendment to their loan documents, preventing conversion of loans into common stock beyond this threshold. The amendment, effective June 23, 2026, details that lenders can convert up to $3 million of outstanding princi

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 21:12
Source
Stock Titan
Stock Titan Direct company coverage

CalciMedica (Nasdaq: CALC) raises $15M, maps PAH and PH trial plans

CalciMedica (Nasdaq: CALC) has raised approximately $15 million in upfront gross proceeds, with potential for up to $49 million through warrant exercises, from a private placement to advance its pulmonary hypertension (PH) program. The company plans to use these funds for a Phase

Tone
Positive 71/100
Event
Market update
Published
24 Jun 2026 21:09
Source
Stock Titan
Stock Titan Direct company coverage

CalciMedica (NASDAQ: CALC) extends Avenue loan and issues new $1.00 warrants

CalciMedica (NASDAQ: CALC) has amended its loan and warrant agreements with Avenue funds, extending the maturity of its $10 million loan to September 1, 2029, and the interest-only period to September 30, 2027. In exchange, the company agreed to a $200,000 increase in the final p

Tone
Neutral 50/100
Event
Market update
Published
24 Jun 2026 20:11
Source
Stock Titan